NOVAVAX INC Income Statement
NVAX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
NOVAVAX INC reported $1.1B in revenue and $440M in net income for FY2025. Revenue has grown at a 36.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $682.2M | $983.7M | $475.6M | $1.1B | $475.6M | $31.2M | $15.4M | $36.3M | $30.7M | $20.9M | $22.1M | $20.9M | $343.0K | $14.7M |
| Cost of Revenue | $73.0M | $202.7M | $343.8M | $0 | $0 | $0 | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $157.5M | $337.2M | $468.9M | $145.3M | $298.4M | $145.3M | $34.5M | $46.5M | $30.8M | $19.9M | $14.8M | $10.1M | $14.8M | $10.8M | $10.9M |
| R&D Expense | $342.3M | $391.2M | $737.5M | $747.0M | $2.5B | $747.0M | $168.4M | $237.9M | $162.6M | $94.4M | $58.5M | $26.9M | $58.5M | $28.0M | $18.4M |
| Operating Income | $452.8M | -$248.9M | -$566.5M | -$416.7M | -$1.7B | -$416.7M | -$171.7M | -$269.1M | -$157.2M | -$83.7M | -$52.4M | -$29.7M | -$52.4M | -$38.5M | -$21.6M |
| Interest Expense | $11.5M | $10.4M | $14.4M | $15.1M | $21.1M | $15.1M | $14.1M | $13.0M | $241.0K | $157.0K | $160.0K | $32.0K | $160.0K | $9.0K | $9.0K |
| Income Tax | $1.9M | $10.9M | $2.0M | $0 | $29.2M | $0 | - | - | - | - | $25.0K | $0 | $25.0K | $450.0K | $412.0K |
| Net Income | $440.3M | -$187.5M | -$545.1M | -$418.3M | -$1.7B | -$418.3M | -$183.8M | -$280.0M | -$156.9M | -$82.9M | -$52.0M | -$28.5M | -$52.0M | -$35.7M | -$19.4M |
| EPS (Basic) | -$5.41 | -$8.42 | -$23.44 | -$7.27 | -$5.51 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$5.41 | -$8.42 | -$23.44 | -$7.27 | -$5.51 | -$9.99 | -$12.56 | -$1.03 | -$0.60 | -$0.37 | -$0.31 | -$0.22 | -$0.17 | -$0.34 | - |
| Shares Outstanding | 160.4M | 139.5M | 86.0M | 75.8M | 71.0M | 32.4M | 19.2M | 323.2M | 271.2M | 270.0M | 238.8M | 208.7M | 147.9M | 117.0M | 113.6K |
| Operating Margin | 40.3% | -36.5% | -57.6% | -87.6% | -147.1% | -87.6% | -550.8% | -1752.8% | -433.8% | -273.0% | -250.7% | -134.4% | -250.7% | -11222.7% | - |
| Profit Margin | 39.2% | -27.5% | -55.4% | -87.9% | -152.1% | -87.9% | -589.5% | -1823.5% | -432.9% | -270.5% | -248.5% | -129.1% | -248.5% | -10410.5% | -131.8% |